T2	Participants 534 700	6350 healthy infants by 2 months of age who presented for primary care at 1 of 2 urban hospitals or 1 of 2 small town/rural and 4 suburban private pediatric practices
T1	Participants 1006 1119	Children who met specified minimum criteria regarding the persistence of MEE became eligible for a clinical trial
